DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,687,000 | +2.9% | 12,111 | -9.3% | 0.37% | +11.9% |
| Q2 2021 | $3,582,000 | +1.5% | 13,348 | -3.9% | 0.33% | +3.5% |
| Q1 2021 | $3,528,000 | +5.7% | 13,894 | -7.6% | 0.32% | -0.9% |
| Q4 2020 | $3,339,000 | -1.1% | 15,032 | -4.1% | 0.32% | -9.9% |
| Q3 2020 | $3,376,000 | +20.3% | 15,677 | -1.2% | 0.35% | +13.5% |
| Q2 2020 | $2,806,000 | -19.6% | 15,871 | -37.1% | 0.31% | +1.0% |
| Q1 2020 | $3,491,000 | -40.9% | 25,220 | -34.5% | 0.31% | +13.6% |
| Q4 2019 | $5,907,000 | +6.0% | 38,490 | -0.2% | 0.27% | +0.7% |
| Q3 2019 | $5,572,000 | +3.0% | 38,581 | +1.9% | 0.27% | +1.9% |
| Q2 2019 | $5,411,000 | +11.8% | 37,862 | +3.2% | 0.26% | +7.3% |
| Q1 2019 | $4,841,000 | +34.3% | 36,671 | +4.9% | 0.25% | +11.3% |
| Q4 2018 | $3,604,000 | -8.6% | 34,949 | -3.6% | 0.22% | +20.0% |
| Q3 2018 | $3,941,000 | +9.0% | 36,268 | -1.0% | 0.18% | +5.7% |
| Q2 2018 | $3,615,000 | +2.6% | 36,633 | +1.8% | 0.18% | +6.1% |
| Q1 2018 | $3,522,000 | -23.7% | 35,973 | -27.6% | 0.16% | +6.5% |
| Q4 2017 | $4,614,000 | -0.1% | 49,707 | -7.7% | 0.16% | +1.3% |
| Q3 2017 | $4,619,000 | +1.0% | 53,842 | -0.7% | 0.15% | -3.2% |
| Q2 2017 | $4,575,000 | -15.5% | 54,208 | -14.3% | 0.16% | -9.7% |
| Q1 2017 | $5,412,000 | +23.7% | 63,281 | +12.6% | 0.18% | +6.1% |
| Q4 2016 | $4,374,000 | -8.2% | 56,192 | -7.6% | 0.16% | -2.4% |
| Q3 2016 | $4,765,000 | -19.8% | 60,783 | +3.3% | 0.17% | -25.9% |
| Q2 2016 | $5,942,000 | +7.3% | 58,829 | +0.8% | 0.23% | +3.2% |
| Q1 2016 | $5,536,000 | -7.4% | 58,360 | -9.3% | 0.22% | -2.6% |
| Q4 2015 | $5,977,000 | +13.1% | 64,350 | +3.7% | 0.23% | +4.6% |
| Q3 2015 | $5,286,000 | -2.3% | 62,036 | -1.9% | 0.22% | +1.9% |
| Q2 2015 | $5,413,000 | -9.2% | 63,239 | -10.0% | 0.21% | +3.9% |
| Q1 2015 | $5,964,000 | -1.0% | 70,247 | -0.1% | 0.20% | -0.5% |
| Q4 2014 | $6,025,000 | -7.0% | 70,296 | -17.5% | 0.21% | +6.2% |
| Q3 2014 | $6,476,000 | +3.5% | 85,235 | +7.3% | 0.19% | +2.1% |
| Q2 2014 | $6,254,000 | +3.3% | 79,431 | -1.7% | 0.19% | +0.5% |
| Q1 2014 | $6,057,000 | -14.2% | 80,765 | -11.7% | 0.19% | -3.1% |
| Q4 2013 | $7,059,000 | -4.2% | 91,443 | -13.9% | 0.20% | +6.0% |
| Q3 2013 | $7,365,000 | +0.2% | 106,243 | -8.5% | 0.18% | +7.6% |
| Q2 2013 | $7,348,000 | – | 116,094 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |